# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-22-106850
Filing Date
2022-04-15
Accepted
2022-04-15 16:31:37
Documents
3
Period of Report
2022-06-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | d352067dpre14a.htm | PRE 14A | 550868
2 | GRAPHIC | g352067g01a11.jpg | GRAPHIC | 394728
3 | GRAPHIC | g352067g02s33.jpg | GRAPHIC | 229133
| Complete submission text file | 0001193125-22-106850.txt |  | 1410768

Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33038 | Film No.: 22830334
SIC: 2834 Pharmaceutical Preparations